Halfon, Philippe

Publishing since 1988 (Dinosaur)

Has published 120 publications in 23 years

Number of publications published per year by Halfon, Philippe. (Source : PubMed)

Distribution of publications types for Halfon, Philippe. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Halfon P, Martinot-Peignoux M, Khiri H, Marcellin P. Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability.  Hepatology  2010  
•  Halfon P, Benmoura D, Agostini A, Khiri H, Martineau A, Penaranda G, Blanc B. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.  J. Clin. Virol.  2010;47;2  
•  Halfon P, Benmoura D, Khiri H, Penaranda G, Blanc B, Riggio D, Sandri MT. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay.  J. Clin. Virol.  2010;47;1  
•  Martinot-Peignoux M, Khiri H, Leclere L, Maylin S, Marcellin P, Halfon P. Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.  J. Clin. Virol.  2009;46;3  
•  Halfon P, Martinot-Peignoux M, Cacoub P. The myth of occult hepatitis C infection.  Hepatology  2009;50;5  
•  Halfon P, Retornaz F, Mathieu D, Helbert T, Philibert P, Pégliasco H. Virus-Associated Hemophagocytic Syndrome related to acute CMV and HBV sexual co-infection: a case report.  J. Clin. Virol.  2009;46;2  
•  Cacoub P, Halfon P. [Virological monitoring of hepatitis C treatment in 2009]  Rev Med Interne  2009;30;10  
•  Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, Guiguen A, Verdin E, Olive D, Van Lint C, Hejnar J, Hirsch I. CpG methylation controls reactivation of HIV from latency.  PLoS Pathog.  2009;5;8  
•  Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.  Aliment. Pharmacol. Ther.  2009;30;1  
•  Halfon P, Ouzan D. [Optimal virologic monitoring of hepatitis C in 2009: Treatment duration depends on the speed of virologic response and the duration of the negative reaction]  Presse Med  2009;38;7-8  

[ See timeline ] [ See all publications ]